Since the beginning of the pandemic, researchers worldwide have been looking for ways to treat COVID-19. And while the COVID-19 vaccines represent the best measure to prevent the disease, therapies for those who do get infected remain in short supply. A new groundbreaking study from U-M reveals several drug contenders already in use for other purposes – including one dietary supplement – that have been shown to block or reduce SARS-CoV2 infection in cells.
Existing drugs kill SARS-CoV2 in cells
August 19, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022